Diagnostic Oncology CRO

Diagnostic Oncology CRO (DOCRO) is a specialized contract research organization providing end-to-end clinical trial services exclusively for the oncology sector. Founded in 2006, the company supports biotechnology and pharmaceutical clients in the development of novel cancer therapeutics and molecular diagnostics. Their service portfolio includes clinical trial design, regulatory affairs, site management, and data analysis, with a particular emphasis on precision medicine and biomarker-driven studies. DOCRO leverages its deep domain expertise to streamline the path from preclinical research to commercialization for complex oncology programs. The firm is recognized for its ability to integrate advanced genomic and proteomic data into clinical development strategies.